Literature DB >> 1995048

Prognostic significance of the pattern visual evoked potential in ocular hypertension.

L C Bray1, K W Mitchell, J W Howe.   

Abstract

This paper reports a prospective study on 49 ocular hypertensive patients to evaluate the prognostic significance of transient abnormalities in the pattern visual evoked potential (VEP) in the development of glaucoma. Seven of 24 patients with VEP abnormalities at diagnosis of ocular hypertension developed glaucomatous field defects in the follow-up period as compared with none of 25 patients with normal VEPs at diagnosis. We conclude that appropriately designed pattern VEP testing is a valuable complement to careful (preferably computerised, static) perimetry. In addition, our findings support the contention that, in glaucomatous disease of the optic nerve, rudimentary pattern processing mechanisms--that is 'Y'-type units of the magnocellular pathways--may be affected earlier than luminance processing mechanisms.

Entities:  

Mesh:

Year:  1991        PMID: 1995048      PMCID: PMC504118          DOI: 10.1136/bjo.75.2.79

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  The Framingham Eye Study. I. Outline and major prevalence findings.

Authors:  H A Kahn; H M Leibowitz; J P Ganley; M M Kini; T Colton; R S Nickerson; T R Dawber
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

2.  Acquired color defects in patients with open-angle glaucoma and ocular hypertension.

Authors:  G A Fishman; A E Krill; M Fishman
Journal:  Mod Probl Ophthalmol       Date:  1974

3.  The Bedford glaucoma survey. I. Long-term follow-up of borderline cases.

Authors:  E S Perkins
Journal:  Br J Ophthalmol       Date:  1973-03       Impact factor: 4.638

4.  Visual evoked responses in the assessment of field defects in glaucoma.

Authors:  J M Cappin; S Nissim
Journal:  Arch Ophthalmol       Date:  1975-01

5.  A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma.

Authors:  G B Arden; J J Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-01       Impact factor: 4.799

6.  The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate.

Authors:  V L Towle; A Moskowitz; S Sokol; B Schwartz
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-02       Impact factor: 4.799

7.  Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy.

Authors:  H A Quigley; E M Addicks; W R Green
Journal:  Arch Ophthalmol       Date:  1982-01

8.  Multichannel evoked potential fields show different properties of human upper and lower hemiretina systems.

Authors:  D Lehmann; W Skrandies
Journal:  Exp Brain Res       Date:  1979-03-09       Impact factor: 1.972

9.  The optic disc in glaucoma II: correlation of the appearance of the optic disc with the visual field.

Authors:  R A Hitchings; G L Spaeth
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

10.  Photogrammetry of the optic disc in glaucoma and ocular hypertension with simultaneous stereo photography.

Authors:  C A Johnson; J L Keltner; M A Krohn; G L Portney
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-12       Impact factor: 4.799

View more
  4 in total

1.  Cortical potentials to pattern reversal and luminance onset under ramp stimulation conditions in glaucoma.

Authors:  P Mierdel; H J Zenker; E Marré
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Pattern visual evoked potential in ocular hypertension.

Authors:  R A Hitchings
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

3.  Neural conduction in the visual pathways in ocular hypertension and glaucoma.

Authors:  V Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

4.  Bilateral asymmetry improved accuracy when assessing glaucomatous vision-related quality of life impairment.

Authors:  Li Yang; Xin Tang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.